Moving beyond single gene correction therapiesto deliver new treatments.
We are a clinical-stage genomic medicines company leading a step shift in how ocular diseases are treated. We are going beyond single gene correction therapies to deliver new treatments to patients affected by Inherited Retinal Diseases (IRDs), regardless of genetic cause.
Our goal is to harness the potential of gene therapy and genome editing to bring cutting-edge innovation into ocular disease drug discovery and development.
At the heart of this is a pipeline of mutation independent treatments for Inherited Retinal Diseases (IRD) such as Retinitis Pigmentosa (RP),the leading inherited cause of blindnesswhich affects 2 million people worldwide.
A group of IRDs which are a leading cause of blindness globally. Current monogenictreatment approaches are not applicable to all patients. With our approach we believe that we can bring meaningful differences to many of them.
Mutations in more than 70 genes
are known to cause RP
Forty thousand people
are affected by RP in France
Two million people are
affected by RP in the world
Combining 20+ years of world-leading ophthalmic research with a world class team of experts from across the international drug development spectrum. SparingVision has an unparalleled understanding of retinal disease and bringing novel treatments to patients.
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
This cookie, set by Cloudflare, is used to support Cloudflare Bot Management.
Further information: https://developers.cloudflare.com/fundamentals/reference/policies-compliances/cloudflare-cookies/#__cf_bm-cookie-for-cloudflare-bot-products
Set by the GDPR Cookie Consent plugin, this cookie records the user consent for the cookies in the "Analytics" category.
Set by the GDPR Cookie Consent plugin, this cookie records the user consent for the cookies in the "Necessary" category.
CookieYes sets this cookie to record the default button state of the corresponding category and the status of CCPA. It works only in coordination with the primary cookie.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
1 year 1 month 4 days
We embed videos from our official Vimeo channel. When you press play Vimeo may set cookies to enable the video to play and maintain the security of its service. These cookies do not directly identify anyone.
If you have a Vimeo account and are logged in, Vimeo may set cookies for analytics and advertising purposes and collect data linked to your Vimeo account when you visit a page containing a Vimeo video. For more information, see the Vimeo cookies policy.